Skip to content

Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

Liver Dysfunction | Liver Regeneration | Liver Metastasis Colon Cancer

The primary objective of this interventional study is determine if the future liver remnant can be optimized by improving liver function pre-operatively in patients who are scheduled for major hepatectomy. The main questions it aims to answer are:

1. Does high-dose insulin therapy improve liver function in the pre-operative setting?
2. What is the effect of high-dose insulin therapy on liver function and liver regeneration after a liver venous deprivation (LVD) procedure?
3. What is the relationship between volume hypertrophy and function in the regenerating liver? Participants will receive a 6-hour infusion of insulin and dextrose to maintain a hyperinsulinemic-normoglycemic state in the weeks prior to planned liver surgery to assess its effect on liver function measured by 99m-Tc-Mebrofenin hepatobiliary scintigraphy.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Age \> 18 years old
* Candidate for major liver resection
* Resectable colorectal liver metastasis

Exclusion Criteria:

* Inability to give consent
* Type 1 diabetes mellitus
* Uncontrolled blood glucose levels (fasting level \> 10 mmol/L)
* Unresectable colorectal liver metastasis
* Extrahepatic metastatic disease that is unresectable

Study Location

McGill Univeristy Health Centre
McGill Univeristy Health Centre
Montreal, Quebec
Canada

Contact Study Team

Primary Contact

Jennifer Kalil, MD

[email protected]
514-934-1934
Study Sponsored By
McGill University Health Centre/Research Institute of the McGill University Health Centre
Participants Required
More Information
Study ID: NCT06126419